Dexcom Crashes As A Key Executive Plans Departure Amid Stelo Launch
In this article:
Dexcom stock crashed late Thursday though the diabetes devices player beat third-quarter expectations and reiterated its guidance.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.